Overview of Dr. Shah
Dr. Nikita Shah is an oncologist in Orlando, FL and is affiliated with Orlando Health Orlando Regional Medical Center. She received her medical degree from Baroda Medical College and has been in practice 26 years. Dr. Shah accepts several types of health insurance, listed below. She is one of 74 doctors at Orlando Health Orlando Regional Medical Center who specialize in Oncology. She has 5 publications and over 500 citings.
Office
1400 S Orange Ave
Orlando, FL 32806
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1998 - 1999
- Presence Saint Francis HospitalFellowship, Hematology, 1996 - 1997
- Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1993 - 1996
- Baroda Medical CollegeClass of 1991
Certifications & Licensure
- FL State Medical License 1999 - 2026
- IL State Medical License 1993 - 2002
- American Board of Internal Medicine Medical Oncology
- ABIMMedical Oncology and Hematology
Awards, Honors, & Recognition
- Best Doctors Orlando Magazine, 2007-2018
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsA Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metas...Ami N Shah, Cesar A Santa-Maria, Dhruvika Mukhija, Nikita Shah, Anthony K Kang
Clinical Breast Cancer. 2023-04-01 - 480 citationsSacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat, Sara M. Tolaney, Steven J. Isakoff
The New England Journal of Medicine. 2019-02-20 - 40 citationsLCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.Amanda E.D. Van Swearingen, Marni B. Siegel, Allison M. Deal, Maria J. Sambade, Alan P. Hoyle
Breast Cancer Research and Treatment. 2018-06-25
Press Mentions
- 1 in 5 Young Women Has No Plans to Get a MammogramSeptember 29th, 2022
- Survey Finds Alarming Number of Young Women Have No Plans of Getting MammogramsSeptember 28th, 2022
- Survey: 22% of Women Aged 35 to 44 Have Never Gotten a Mammogram, Have No Plans to Get OneSeptember 28th, 2022
- Join now to see all
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Illinois BlueChoice Select
BCBS Illinois HMO
BCBS Illinois PPO
CIGNA HMOCIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: